Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment By Line of Therapy in Patients with Chronic Lymphocytic Leukemia and/or Small Lymphocytic Lymphoma

被引：0
|
作者：
Jacobs, Ryan W. [1 ]
Teschemaker, Anna [2 ]
Hakre, Shweta [2 ]
Tian, Hongping [3 ]
Pyrih, Nick [3 ]
Wahlstrom, Svea K. [4 ]
Cui, Lianzhou [3 ]
机构：
[1] Atrium Hlth Levine Canc Inst, Charlotte, NC USA
[2] AstraZeneca, Gaithersburg, MD USA
[3] Cobbs Creek Hlth Care, Newtown Sq, PA USA
[4] AstraZeneca, Wilmington, DE USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174974
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia
    Lu, Xiaoxiao
    Emond, Bruno
    Morrison, Laura
    Kinkead, Frederic
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Khan, Wasiulla
    Wu, Linda H.
    Qureshi, Zaina P.
    Jacobs, Ryan
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 2073 - 2084
  • [42] Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients
    Yazdy, Maryam Sarraf
    Mato, Anthony R.
    Roeker, Lindsey E.
    Jarral, Umair
    Ujjani, Chaitra S.
    Shadman, Mazyar
    Skarbnik, Alan
    Whitaker, Kate J.
    Deonarine, Isaac
    Kabel, Charlene C.
    Stump, Sarah E.
    Goodfriend, Julie
    Pagel, John M.
    Bailey, Neil
    Patel, Krish
    Jacobs, Ryan
    Feldman, Tatyana A.
    Leslie, Lori A.
    Goy, Andre
    Coombs, Catherine C.
    Muluneh, Benyam
    Khajavian, Sirin
    Lamanna, Nicole
    Weissbrot, Hanna
    Weiss, Jessica
    Cheson, Bruce D.
    BLOOD, 2019, 134
  • [43] Real-world evidence study of treatment patterns and outcomes following covalent BTKi discontinuation in a contemporary cohort of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients
    Lin, Kevin H.
    Huynh, Lynn
    Yang, Xiaoqin
    Zanardo, Enrico
    Lema, Neema
    Matay, Lisa
    Balasubramanian, Sobana
    Liborski, Daria
    McDonough, Mikaela
    Foreman, Jillian
    Farooqui, Mohammed Z. H.
    De Nigris, Enrico
    Gandra, Shravanthi R.
    Sarpong, Eric M.
    Duh, Mei Sheng
    Brown, Jennifer R.
    Davids, Matthew Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia
    Vainer, Noomi
    Aarup, Kathrine
    Andersen, Michael Asger
    Wind-Hansen, Lise
    Nielsen, Tine
    Frederiksen, Henrik
    Enggaard, Lisbeth
    Poulsen, Christian Bjorn
    Niemann, Carsten U.
    Rotbain, Emelie C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (05) : 874 - 886
  • [45] Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma
    Barrientos, Jacqueline C.
    FUTURE ONCOLOGY, 2016, 12 (18) : 2077 - 2094
  • [46] Real-World Evaluation of the Treatment Landscape for Chronic Lymphocytic Leukemia
    Smith, Timothy W.
    Owusu, Henry F.
    Wormser, David
    Woo, Janghee
    BLOOD, 2021, 138
  • [47] Real-World Persistence and Time to Next Treatment with Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke
    Narezkina, Anna
    Lu, Xiaoxiao
    Emond, Bruno
    Cote-Sergent, Aurelie
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    BLOOD, 2021, 138
  • [48] Real-world treatment patterns in first line and relapsed Chronic Lymphocytic Leukemia (CLL)
    Feinberg, Bruce
    Schenkel, Brad
    McBride, Ali
    Ellis, Lorie
    Radtchenko, Janna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S204 - S205
  • [49] Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke
    Narezkina, Anna
    Akhter, Nausheen
    Lu, Xiaoxiao
    Emond, Bruno
    Panjabi, Sumeet
    Forbes, Shaun P.
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    Choi, Michael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (11): : E959 - E971
  • [50] Early Adherence and Persistence to First-Line Ibrutinib or Acalabrutinib Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Atrial Fibrillation
    Fradley, Michael
    Lafeuille, Marie-Helene
    Emond, Bruno
    Crawford, Samuel
    Chen, Naijun
    Volodarsky, Raisa
    Nielsen, Jacqueline
    Srivastava, Bhavini Patel
    BLOOD, 2022, 140 : 10983 - 10984
12345